Oxazepam Léčiva

Oxazepam, the active ingredient in Oxazepam Léčiva, is a benzodiazepine presented as a tablet for oral use. It is primarily prescribed for the short‑term management of anxiety disorders and related conditions in adults. GNH USA supplies Oxazepam Léčiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxazepam Léčiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxazepam is a benzodiazepine that acts on the central nervous system to alleviate anxiety‑related conditions.

- Anxiety disorder: reduces excessive worry and tension in adults. - Alcohol withdrawal: helps control agitation and tremor during detoxification. - Acute insomnia related to anxiety: promotes sleep onset when anxiety is a contributing factor.

Oxazepam may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate head pain. - Fatigue: reduced energy and motivation. - Nausea: upset stomach or feeling of needing to vomit. - Impaired coordination: clumsiness or reduced motor control.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with other depressants. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Depression or suicidal thoughts: worsening mood or emergence of self‑harm ideation. - Paradoxical aggression: unexpected agitation, hostility, or violent behaviour. - Withdrawal seizures: seizures occurring after abrupt discontinuation. - Hepatic dysfunction: abnormal liver enzyme elevations indicating liver stress.

When prescribing Oxazepam, clinicians should consider several safety aspects.

- Assess patient history: evaluate for prior benzodiazepine dependence or substance abuse. - Monitor renal and hepatic function: dose adjustments may be needed in impairment. - Avoid abrupt discontinuation: taper gradually to reduce withdrawal risk. - Caution in elderly: increased sensitivity to sedation and falls. - Contraindications: do not use in patients with acute narrow‑angle glaucoma. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxazepam can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use can cause profound respiratory depression. - Barbiturates: additive central nervous system depression leading to excessive sedation. - Alcohol: synergistic sedative effect increasing risk of accidents.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase sedation or serotonin syndrome risk. - Antihistamines: can enhance drowsiness. - Anticonvulsants (phenytoin, carbamazepine): may reduce oxazepam plasma levels. - CYP3A4 inhibitors (ketoconazole, erythromycin): may increase oxazepam concentrations. - CYP3A4 inducers (rifampicin, carbamazepine): may lower oxazepam concentrations.